Cronos Group Inc. (CRON.TO)

CAD 2.72

(-2.51%)

Inventory Summary of Cronos Group Inc.

  • Cronos Group Inc.'s latest annual inventory in 2023 was 30.49 Million USD , down -18.81% from previous year.
  • Cronos Group Inc.'s latest quarterly inventory in 2024 Q2 was 29.18 Million USD , down -4.76% from previous quarter.
  • Cronos Group Inc. reported annual inventory of 37.55 Million USD in 2022, up 14.5% from previous year.
  • Cronos Group Inc. reported annual inventory of 32.8 Million USD in 2021, down -25.45% from previous year.
  • Cronos Group Inc. reported quarterly inventory of 29.18 Million USD for 2024 Q2, down -4.76% from previous quarter.
  • Cronos Group Inc. reported quarterly inventory of 35.84 Million USD for 2023 Q3, down -20.67% from previous quarter.

Annual Inventory Chart of Cronos Group Inc. (2023 - 2013)

Historical Annual Inventory of Cronos Group Inc. (2023 - 2013)

Year Inventory Inventory Growth
2023 30.49 Million USD -18.81%
2022 37.55 Million USD 14.5%
2021 32.8 Million USD -25.45%
2020 44 Million USD 15.66%
2019 38.04 Million CAD 150.83%
2018 15.16 Million CAD 57.13%
2017 9.65 Million CAD 250.34%
2016 2.75 Million CAD 2918.73%
2015 -97.74 Thousand CAD -667.36%
2014 17.22 Thousand CAD 0.0%
2013 - CAD 0.0%

Peer Inventory Comparison of Cronos Group Inc.

Name Inventory Inventory Difference
Aurora Cannabis Inc. 186.37 Million CAD 83.638%
Avicanna Inc. 4.54 Million CAD -571.07%
Avant Brands Inc. 28.93 Million CAD -5.384%
Cardiol Therapeutics Inc. -279.87 Thousand CAD 10996.052%
Crescita Therapeutics Inc. 6.12 Million CAD -397.878%
Knight Therapeutics Inc. 91.83 Million CAD 66.793%
MediPharm Labs Corp. 9.89 Million CAD -208.061%
OrganiGram Holdings Inc. 80.95 Million CAD 62.33%
Canopy Growth Corporation 77.29 Million CAD 60.546%
Willow Biosciences Inc. 221 Thousand CAD -13698.643%
Auxly Cannabis Group Inc. 31.42 Million CAD 2.972%